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ABSTRAK
Latar belakang: penggunaan bioelectrical impedance analysis (BIA) dipengaruhi oleh populasi, jenis 
BIA, dan titik potong yang digunakan. Penelitian ini bertujuan untuk mengetahui performa diagnostik BIA 
untuk mengukur massa otot pada pasien berusia 60 tahun atau lebih di rawat jalan. Metode: uji diagnostik 
potong lintang dilakukan di poliklinik geriatri Rumah Sakit Cipto Mangunkusumo selama bulan April–Juni 
2018. Pengukuran massa otot menggunakan BIA Tanita MC-780MA (Tokyo, Jepang) dengan dual-energy X-ray 
absorptiometry (DXA) sebagai uji referensi. Analisis titik potong berdasarkan kriteria Asian Working Group of 
Sarcopenia (AWGS) dan titik potong baru. Hasil: dari 120 subjek didapatkan 74 perempuan (61,7%). Performa 
diagnostik BIA dengan menggunakan acuan AWGS mendapatkan sensitivitas dan spesifisitas hanya 79,2% 
dan 66,7%. Sedangkan performa diagnostik BIA dengan acuan titik potong baru menunjukkan sensitivitas dan 
spesifisitas sebesar 75% dan 92,7%. Titik potong optimal yang baru dengan menggunakan BIA adalah <6,9 Kg/
m2 pada laki-laki (sensitivitas 70,6%; spesifisitas 82,8%) dan <5 kg/m2 pada perempuan (sensitivitas 85,7%; 
spesifisitas 97%). Kesimpulan: BIA Tanita MC-780MA (Tokyo, Jepang) memiliki akurasi diagnostik yang baik 
untuk mengukur massa otot pada pasien lanjut usia dengan menggunakan titik potong laki-laki kurang dari 6,9 
kg/m2, sedangkan pada perempuan kurang dari 5 kg/m2.
Kata kunci: BIA Tanita MC-780MA, Indonesia, lanjut usia, massa otot, sarkopenia.
ABSTRACT
Background: the use of bioelectrical impedance analysis (BIA) is affected by the population setting, the type 
of BIA, and the cut-off point being used. The aim of this study was to determine the diagnostic performance of 
BIA to measure muscle mass in Indonesian elderly outpatients aged 60 years or more. Methods: a cross-sectional 
study was conducted at the Geriatric Clinic of Cipto Mangunkusumo Hospital from April to June 2018. The muscle 
mass was measured using BIA Tanita MC-780MA (Tokyo, Japan) with dual-energy x-ray absorptiometry (DXA) as 
the reference test. Analysis on the cut-off point was performed based on the Asian Working Group of Sarcopenia 
(AWGS) criteria and the new cut-off point. Results: from 120 subjects, 74 were female (61.7%). The diagnostic 
performance of BIA based on AWGS criteria only showed sensitivity and specificity of 79.2% and 66.7%. The 
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diagnostic performance of BIA based on the new cut-off point showed sensitivity and specificity of 75% and 92.7%. 
The new cut-off point using BIA was found to be <6.9 kg/m2 in males (sensitivity 70.6%; specificity 82.8%) and 
<5 kg/m2 in females (sensitivity 85.7%; specificity 97%). Conclusion: the diagnostic performance of BIA Tanita 
MC-780MA (Tokyo, Japan) was good to measure muscle mass in Indonesian elderly outpatients using a new cut-
off point of <6.9 kg/m2 for males and <5 kg/m2 for females.
Keywords: BIA Tanita MC-780MA, elderly, Indonesia, muscle mass, sarcopenia.
INTRODUCTION
The elderly population is rapidly growing, 
and is predicted to be doubled by 2050, from 
11% to 22%.1 The Indonesian Central Bureau 
of Statistics (BPS) predicted that there will be 
a surge of elderly population (aged 60 years or 
more) in Indonesia, from 9% in 2015 to 19.8% 
in 2045.2 Several complex health problems 
could arise from geriatric patients—more widely 
known as geriatric syndrome—and one of these 
is sarcopenia.3
The European Working Group on Sarcopenia 
in Older People (EWGSOP) and the Asian 
Working Group of Sarcopenia (AWGS) defined 
sarcopenia as an age-related decline in muscle 
strength and/or performance in addition to 
progressive decrease in muscle mass resulting 
in an increased risk of falling, hospitalization, 
disability, poor quality of life, and mortality.3,4 
The essential part of the sarcopenia diagnostic 
algorithm is the measurement of muscle mass. 
Magnetic Resonance Imaging (MRI) and 
Computed Tomography (CT) scan are the gold 
standard methods for muscle mass measurement, 
nonetheless both methods are high cost and 
require highly trained human resources.3,5
Dual-energy X-ray Absorptiometry (DXA) is 
a widely used device to measure body composition 
that also serves as the best alternative to measure 
muscle mass in research and clinical practice.6 
Another non-invasive device recommended 
by EWGSOP and AWGS for muscle mass 
measurement, yet more practical, easier to use 
with lower cost, and less resources than DXA is 
the Bioelectrical Impedance Analysis (BIA).3,4 The 
BIA is a method that estimates body composition 
based on the relationship between the volume of a 
conductor and its electrical resistance.7 Previous 
studies indicated that the diagnostic performance 
of BIA in muscle mass measurement was affected 
by the population setting, the type of BIA, and 
the cut-off point being used.4,8-10 Up to the present 
time, there is no study that has investigated the 
diagnostic performance of BIA compared with 
DXA as the reference test to measure muscle mass 
in Indonesian elderly. Therefore, this study was 
aimed to investigate the diagnostic performance of 
BIA compared with DXA to measure the muscle 
mass as a component of sarcopenia in Indonesian 
elderly outpatients aged 60 years or older.
METHODS
This cross-sectional study of the diagnostic 
test was conducted on patients aged 60 years 
or more who were consecutively recruited at 
the Geriatric Clinic of Cipto Mangunkusumo 
Hospital, Jakarta, Indonesia from April to June 
2018. This study was approved by the Ethical 
Committee of the Faculty of Medicine Universitas 
Indonesia/Cipto Mangunkusumo Hospital 
on February 19, 2018 with reference number 
0137/UN.2F1/ETIK/2018. The study enrolled 
patients aged 60 years and older who were able 
to undergo BIA and DXA examinations. Patients 
with acute conditions (e.g., pneumonia, acute 
heart failure, or acute osteoarthritis), inability to 
walk, and to understand the instructions of the 
study, conditions which will interfere with DXA 
measurement including inability to lie down in a 
supine position, as well as those who have limb 
amputation and/or edema, Parkinson disease, or 
other medical conditions with tremor, weighed 
more than 100 kg, using artificial implants, and 
refused to participate in this study were excluded.
Muscle mass measurement was performed 
using BIA Tanita MC-780MA (Tokyo, Jepang) 
with DXA as the reference test. The BIA 
measurement was conducted at the Center for 
Sport and Exercise Studies, Indonesia Medical 
Education and Research Institute (IMERI) Faculty 
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of Medicine Universitas Indonesia. For BIA 
measurement, the subjects need to stand on their 
bare feet and then wait for the results printed from 
the device. The muscle mass of all four extremities 
were calculated to obtain the Appendicular 
Skeletal Mass (ASM). Then, the value of ASM 
was divided by the square of the height in meters 
to obtain the Appendicular Skeletal Muscle Index 
(ASMI) value (kg/m2). Each subject underwent 
DXA measurement at the Osteoporosis Center-
Medistra Hospital, Jakarta, Indonesia, in which 
the subject needs to lie down in the supine position 
on a DXA table with the extremities close to the 
body. The muscle mass index was then classified 
as low or normal based on the cut-off point value 
according to AWGS criteria (for BIA: males <7 
kg/m2 and females <5.7 kg/m2; for DXA: males 
<7 kg/m2 and females <5.4 kg/m2).
The usual gait speed on a 6-meter straight 
line was measured using a stopwatch. The 
measurement of handgrip strength was performed 
using a hydraulic Jamar J00105 [Jamar, IA, USA] 
in sitting position on the dominant hand and 
only the highest handgrip strength out of three 
trials was documented. The muscle strength and 
performance were also classified as low or normal 
based on the cut-off point value according to 
AWGS criteria.
Statistical Analysis
The IBM SPSS Statistics for Windows 
version 20.0 (IBM Corp., Armonk, NY, USA) 
was used to analyze the data. The value of 
statistical power and a were set at 80% and 5%, 
respectively. The minimum sample size was 105 
subjects. Descriptive data on demographic (age 
and sex), anthropometric (body weight, height 
estimation based on knee-height, and body mass 
index), and clinical characteristics of the subjects 
were presented as percentage, mean (standard 
deviation), or median (minimal–maximal) value 
where appropriate. The values of area under the 
curve (AUC) and optimal cut-off point for muscle 
mass index were set according to the receiver 
operating characteristic (ROC) curve. The cut-off 
point of muscle mass index was then classified as 
low or normal and analyzed using a 2 x 2 table 
to determine the sensitivity, specificity, positive 
predictive values (PPV), negative predictive 
values (NPV), positive likelihood ratio (LR+), 
and negative likelihood ratio (LR–) values.
RESULTS
Out of 142 subjects who met the inclusion 
criteria, 22 subjects were scheduled. From 120 
subjects in the final analysis, 74 were female 
(61.7%) and 46 were male (38.3%). The subjects’ 
characteristics can be seen in Table 1, whereas 
the profile of sarcopenia’s components based on 
age group is shown in Table 2. The mean ASMI 
in sarcopenic and non-sarcopenic male subjects 
were 6.57 (0.52) kg/m2 and 7.83 (0.76) kg/m2, 
respectively, while in females they were 5.08 
(0.34) kg/m2 and 6.64 (0.74) kg/m2, respectively.
The diagnostic performance of BIA Tanita 
MC-780MA based on AWGS criteria showed 
sensitivity, specificity, PPV, NPV, LR+, LR–, and 
AUC values of 79.2%, 66.7%, 37.3%, 92.8%, 
Table 1. Subject characteristics
Male  
(n = 46)
Female  
(n = 74)
Age (years), n (%) 71.89 (6.11)a
 - 60–69 16 (34.8) 26 (35.1)
 - 70–79 25 (54.3) 41 (55.4)
 - >80 5 (10.9) 7 (9.5)
BMI (kg/m2)
22.48 (4.60)a
21.87 (3.84)a 22.86 (5.00)a
Handgrip strength (kg)
20 (10–40)b
26.13 (6.24)a 18.00 (10–35)b
Usual gait speed  
(m/sec)
0.76 (0.23)a
0.78 (0.22)a 0.75 (0.23)a
ASMI based on BIA 
(kg/m2) 7.41 (1.35)
a 6.00 (0.84)a
ASMI based on DXA 
(kg/m2) 7.45 (0.91)
a 6.53 (0.82)a
Muscle mass classification based on BIA
 - Low 19 (41.3) 32 (43.2)
 - Normal 27 (58.7) 42 (56.8)
Muscle mass classification based on DXA
 - Low 17 (37.0) 7 (9.5)
 - Normal 29 (63.0) 67 (90.5)
Sarcopenia status based on BIA
 - Sarcopenia 12 (26.1) 24 (32.4)
 - Normal 34 (73.9) 50 (67.6)
Sarcopenia status based on DXA
 - Sarcopenia 14 (30.4) 5 (6.8)
 - Normal 32 (69.9) 69 (93.2)
a mean (standard deviation)
b median (minimal–maximal)
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Indonesian Population Projection in 2017 in 
which the proportion of elderly females was 
higher than males (52.53% vs 47.47%).2 The 
mean age of subjects was 71.87 (6.10) years with 
the highest proportion (55%) in the age range 
of 70–79 years old. Although life expectancy in 
Indonesia for the period between 2015–2020 was 
72.51 years, the highest proportion of Indonesian 
elderly in the community was in the age range 
of 60–69 years (63.36%).2
The proportion of sarcopenia in male and 
female groups was quite different based on 
muscle mass measurement between BIA and 
DXA examination. In the female group, BIA 
overestimated sarcopenic subjects by 4.76 times 
compared with DXA. Whereas, in the male 
group, BIA is underestimated as much as 0.86 
times compared with DXA. Hence, it indicates a 
poor diagnostic performance of BIA to diagnose 
declined muscle mass when using the cut-off 
point based on AWGS criteria.
The diagnostic performance of BIA Tanita 
MC-780MA (Tokyo, Japan) based on AWGS 
criteria only showed sensitivity, specificity, PPV, 
NPV, LR+, LR–, and AUC of 79.2%, 66.7%, 
37.3%, 92.8%, 2.38, 0.31, and 0.729 (95% CI 
2.38, 0.31, and 0.729 (95% CI 0.619–0.839), 
respectively. The diagnostic performance of BIA 
Tanita MC-780MA based on AWGS criteria for 
each sex group is shown in Figure 1.
To improve diagnostic performance of 
muscle mass measurement using BIA Tanita 
MC-780MA, we did further statistical analysis 
to determine the optimal cut-off point with higher 
specificity. The new optimal cut-off point was 
found to be <6.9 kg/m2 in males with sensitivity 
70.6%, specificity 82.8%, PPV 70.6%, NPV 
82.8%, LR+ 4.1, LR– 0.4, and AUC 0.767 (95% 
CI 0.616–0.918), whereas it was <5 kg/m2 in 
females with sensitivity 85.7%, specificity 97%, 
PPV 75%, NPV 98.5%, LR+ 28.5, LR– 0.15, 
and AUC 0.914 (95% CI 0.759–1.000). The 
diagnostic performance of BIA based on the 
new cut-off point showed sensitivity, specificity, 
PPV, NPV, LR+, LR–, and AUC of 75%, 92.7%, 
72%, 93.7%, 10.3, 0.3, and 0.839 (95% CI 
0.731–0.946), respectively.
DISCUSSION
There were 120 subjects involved in this 
study, more than half were females (61.7%). 
This proportion was in accordance with the 
Table 2. The profile of sarcopenia components based on age group
Components
Age Group
60–69 years old  
n (%)
70–79 years old 
n (%)
≥80 years old 
n (%)
Sarcopenia Status based on BIA
 - Sarcopenia 7 (16.7) 21 (31.8) 8 (66.7)
 - Normal 35 (83.3) 45 (68.2) 4 (333)
Sarcopenia Status based on DXA
 - Sarcopenia 1 (2.4) 13 (19.7) 5 (41.7)
 - Normal 41 (97.6) 53 (80.3) 7 (58.3)
ASMI based on BIA
 - Low 10 (23.8) 33 (50.0) 8 (66.7)
 - Normal 32 (76.2) 33 (50.0) 4 (33.3)
ASMI based on DXA
 - Low 3 (7.1) 16 (24.2) 5 (41.7)
 - Normal 39 (92.9) 50 (75.8) 7 (58.3)
Handgrip Strength
 - Low 14 (33.3) 26 (39.4) 12 (100)
 - Normal 28 (66.7) 40 (60.6) 0 (0)
Usual Gait Speed
 - Low 23 (54.8) 36 (54.5) 9 (75.0)
 - Normal 19 (45.2) 30 (45.5) 3 (25.0)
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0.619–0.839), respectively. Therefore, when 
using the cut-off point value according to the 
AWGS criteria,4 the muscle mass measurement 
using BIA Tanita MC-780MA was not good as 
either a screening or diagnostic tool. This finding 
is consistent with a study conducted by Reiss et 
al.11 with 60 elderly people which showed that 
BIA sensitivity and specificity were 77% and 
71%, respectively.
From ROC analysis, the AUC value of BIA 
was obtained. In male subjects, the result was 
0.831 (95% CI 0.708–0.953) with a statistically 
significant value of p (p < 0.001). Hence, it can 
be concluded that BIA is good for muscle mass 
measurement in male subjects with AUC value 
>0.8.
After the AUC value was obtained, an 
analysis was performed to determine the optimal 
cut-off point out of 44 cut-off points. Based on the 
Youden index and cut-off point curve, the optimal 
cut-off point of BIA for male subjects was <6.9 
kg/m2, with sensitivity 70.6%, specificity 82.8%, 
PPV 70.6%, NPV 82.8%, LR+ 4.1, LR– 0.4, and 
AUC 0.767 (95% CI 0.616–0.918).
Our optimal cut-off point that indicates low 
muscle mass in males was higher than Yamada et 
al,12,13 slightly less than Yoshida et al,14 and much 
less than was reported in studies by Janssen et 
al15 and Landi et al16. These differences might 
be contributed by differences in ethnic groups 
(Asian vs Caucasian), type of BIA being used, 
the mean age of the subjects, as well as the 
mean ASMI of sarcopenic and non-sarcopenic 
subjects.
The Yamada et al12 study on community-
dwelling elderly in Japan revealed that using 
BIA Inbody 720 (Biospace, Korea) the optimal 
cut-off point of muscle mass for males was <6.75 
kg/m2. However, the mean age of their subjects 
was older than our study with lower mean of 
ASMI. The mean age of their subjects was 74 
(4.8) years in non-sarcopenic and 81.1 (4.8) years 
in sarcopenic subjects with the mean of ASMI 
being 5.53 (0.73) kg/m2 in sarcopenic and 7.16 
(1.01) kg/m2 in non-sarcopenic male subjects. 
A study by Yoshida et al14 on 250 community-
dwelling elderly aged 65 years or more in Japan 
and using a different type of BIA [Tanita MC-
980A (Tokyo, Japan)] reported a slightly higher 
optimal cut-off point for male subjects than our 
finding (<7.09 kg/m2) although the mean age 
of their subjects was older than ours [73.7 (5.7) 
years]. Furthermore, the Janssen et al15 study on 
non-institutionalized elderly in the US found a 
much higher optimal cut-off point that indicates 
low muscle mass in males than our study [≤8.50 
kg/m2 in severe sarcopenia and ≤8.51–10.75 
in moderate sarcopenia]. Janssen et al15 study, 
which used BIA Valhalla 1990B (Valhalla 
Medical, California), had younger mean age 
[70 (7) years] with higher mean ASMI than ours 
[9.86 (1.18) kg/m2]. In contrast, though they had 
much older subjects’ mean age [84.1 (6.9) years], 
using BIA AKERN (Florence, Italy) Landi et al16 
study revealed much higher optimal cut-off point 
for male subjects in Italy than our study (<8.87 
kg/m2). The mean ASMI in Landi et al16 study 
was slightly lower for sarcopenic [6.3 (1.4) kg/
Figure 1. ROC analysis of BIA. Male group (A) and female group (B)
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m2] but much higher for non-sarcopenic subjects 
[11.7 (3.2) kg/m2] than our study.
The ROC analysis on female subjects 
showed a very good AUC value of 0.991 (95% 
CI 0.974–1.000) with a statistically significant p 
value (p< 0.001). Then, an analysis to determine 
the optimal cut-off point out of 70 cut-off points 
was performed. Based on the Youden index and 
the cut-off point curve, it was determined that the 
optimal cut-off point of BIA in female subjects 
was <5 kg/m2 with sensitivity, specificity, PPV, 
NPV, LR+, LR–, and AUC of 85.7%, 97%, 75%, 
98.5%, 28.5, 0.15, and 0.914, respectively.
Our optimal cut-off point that indicates low 
muscle mass in females was much less than 
Yoshida et al,14 Janssen et al,15 and Landi et al16 
study, yet quite similar to Yamada et al12,13 study. 
Similar to the male subjects, Yoshida et al14 also 
found that the optimal cut-off point for female 
subjects was higher than our finding (<5.91 kg/
m2) although the mean age of their subjects was 
older [73.2 (5.5) years]. Similarly, Janssen et 
al15 reported that the optimal cut-off point was 
much higher than our result due to the higher 
mean of ASMI [7.04 (1.11)] kg/m2; ≤5.75 kg/
m2 in severe sarcopenic and 5.76–6.75 kg/m2 in 
moderate sarcopenic subjects], though similar 
mean age [71 (8) years old]. In the same way, 
Landi et al16 found that the optimal cut-off point 
was <6.42 kg/m2. However, a study by Yamada 
et al12 on elderly Japanese patients using BIA 
Inbody 720 (Biospace, Korea) showed a similar 
result to our study (<5.07 kg/m2) although the 
mean age of the subjects was older [73.9 (5.3) 
years in non-sarcopenic and 77.6 (5.4) years 
in sarcopenic female subjects] and the mean 
ASMI was lower than our result (4.23 kg/m2 
and 5.65 kg/m2 in sarcopenic and non-sarcopenic 
females, respectively). All other studies recruited 
community-dwelling older adults, except Landi 
et al16 who recruited the subjects from nursing 
home residents.
A cross-tab analysis was then performed 
between BIA as the diagnostic test and DXA as 
the reference test using the new cut-off point. 
The diagnostic performance of BIA compared 
with DXA was improved. The sensitivity and 
LR– only slightly decreased from 79.2% to 75% 
and from 0.31 to 0.3, respectively. However, the 
specificity, PPV, LR+, and AUC significantly 
increased from 66.7% to 92.7%, from 37.3% to 
72%, from 2.38 to 10.3, and from 0.729 to 0.839, 
respectively, with slightly increased NPV from 
92.8% to 93.7%. The new cut-off point for males 
was only slightly lower than the AWGS criterion 
(<6.9 kg/m2 vs <7 kg/m2), however, the new 
cut-off point for females was much lower than 
the AWGS criterion (<5 kg/m2 vs <5.7 kg/m2).
Our findings show that by using the new 
cut-off points, BIA has high specificity and LR+ 
value. Thus, BIA can serve as a diagnostic tool 
to measure declined muscle mass, which is an 
essential component of the sarcopenia diagnostic 
algorithm. Moreover, our findings also support 
the use of BIA as a valid and practical tool to 
measure muscle mass when MRI, CT scan, 
or DXA is unavailable or when there is cost 
constraint.
Our study was the first study to investigate 
the diagnostic performance of BIA compared 
with DXA to measure muscle mass in Indonesian 
elderly. However, the low proportion of 
sarcopenic female subjects may interfere with 
the diagnostic performance of BIA for elderly 
females. Therefore, further study to investigate 
the external validation of the new muscle 
mass index cut-off point should be performed 
to ascertain whether these new cut-off points 
for both sex groups can be applied to a wider 
population.
CONCLUSION
The diagnostic performance of BIA Tanita 
MC-780MA (Tokyo, Japan) was good to measure 
muscle mass in Indonesian elderly outpatients, 
using a new cut-off point of <6.9 kg/m2 for males 
and <5 kg/m2 for females. The differences in the 
optimal cut-off points which indicate low muscle 
mass reported by several studies emphasize that 
different types of BIA devices can affect the 
results, as well as the age, sex, and ethnicity.
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